|
|
||||||||
Original Research Communications |
1 From the Department of Nutritional Physiology, National Institute of Nutrition, Mexico City; the Program in International Nutrition, University of California, Davis; and the Department of Nutritional Sciences, University of Connecticut, Storrs.
2 Address reprint requests to JL Rosado, National Institute of Nutrition, Department of Nutritional Physiology, Vasco de Quiroga No. 15, Tlalpan, Mexico DF 14000. E-mail: rosado{at}servidor.unam.mx.
| ABSTRACT |
|---|
|
|
|---|
Objective: The objective of this study was to investigate the effect of supplementation with iron, zinc, or both on vitamin A and its metabolically related proteins retinol binding protein (RBP) and transthyretin.
Design: The study was a longitudinal, double-blind, placebo-controlled trial in which 219 rural Mexican children aged 1836 mo were randomly assigned to receive 20 mg Zn/d, 20 mg Fe/d, 20 mg Zn/d plus 20 mg Fe/d, or placebo.
Results: Six months after supplementation, plasma retinol increased in all supplemented groups. Compared with placebo, zinc supplementation was associated with significantly higher plasma retinol and transthyretin but the increase in RBP was not significant. Iron supplementation significantly increased plasma retinol, RBP, and transthyretin. Supplementation with zinc plus iron significantly increased plasma retinol but not RBP or transthyretin. Children deficient in zinc, iron, or vitamin A (as indicated by nutrient plasma concentration) at the beginning of the study had a significantly greater increase in retinol than did children with adequate nutrient status.
Conclusions: Supplementation with zinc, iron, or both improved indicators of vitamin A status. The results of this study agree with previous observations of a metabolic interaction between zinc and vitamin A and suggest an interaction between iron and vitamin A metabolism.
Key Words: Zinc deficiency iron deficiency vitamin A deficiency retinol binding protein RBP transthyretin nutrient interactions preschoolers
| INTRODUCTION |
|---|
|
|
|---|
Interactions between zinc and vitamin A were reported in animals (1522) and humans (2327). Zinc deficiency is commonly associated with low plasma concentrations of vitamin A, even when hepatic vitamin A stores are normal, suggesting that there is a defect in mobilization of vitamin A rather than in its absorption or transport to the liver. With zinc deficiency there is impaired synthesis of proteins that turnover rapidly, such as retinol binding protein (RBP). This impairment affects retinol transport from the liver to the circulation and other tissues because retinol is transported as a retinol-RBP complex in association with transthyretin. Previous reports indicated beneficial effects of zinc supplementation on vitamin A metabolism in malnourished children (23), preterm infants (24), and adults with alcoholic cirrhosis (25). Other studies showed no such effect of zinc on serum indicators of vitamin A metabolism (26, 27). However, a functional interaction between zinc and vitamin A was suggested in that there was significantly less abnormal conjunctival impression cytology in subjects receiving both zinc and vitamin A than in subjects receiving a placebo or zinc alone. These conflicting results may be explained by differences in the subjects' nutritional status for zinc, vitamin A, and perhaps other nutrients (23).
Studies in humans (28, 29) and animals (3032) showed that vitamin A deficiency causes abnormalities in iron metabolism and that supplementation with vitamin A improves iron status as measured by hematologic indexes (3340). No longitudinal studies have evaluated the effect of iron supplementation on vitamin A status. In the present study we investigated the effect of supplementation with iron, zinc, or both on plasma concentrations of retinol, RBP, and transthyretin.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
150 km northwest of Mexico City. The communities ranged in size from 700 to 1500 persons (
100214 households). All children aged 1836 mo were considered as potential participants. According to a baseline census there were 290 children in this age group in the study area. After they learned about the design and potential risks and benefits of the study, the mothers of all of these children were invited to allow their children to participate. The mothers of 219 children agreed to their children's participation and signed consent forms. The protocol was approved by the Committee on Biomedical Research in Human Subjects of the National Institute of Nutrition. The children were assigned to 1 of 4 groups depending on their age, sex, and height-for-age deficit. Birth dates were obtained from birth certificates.
Zinc and iron supplementation
Children in each of the 4 groups received 20 mL/d of a beverage containing 20 mg Fe as ferrous sulfate, 20 mg Zn as zinc methionine, 20 mg Zn plus 20 mg Fe, or placebo. Zinc methionine was chosen after we showed that postconsumption plasma zinc concentrations were higher with this form of zinc than with zinc sulfate or zinc polyascorbate (41). Ferrous sulfate is the most commonly used form of supplemental iron. To improve the taste of the mineral solutions and to ensure that they were similar in appearance, texture, and taste to each other and to the placebo, all beverages contained sugar, citric acid, water, and artificial orange or lemon flavor. The acceptability of the beverage was ensured by testing it before the trial in a sample of children of the same age as the study subjects.
Children in each group were visited at home from Monday through Saturday each week by a fieldworker who gave the beverage to each child and ensured that it was consumed completely. The flavor of the supplement was changed weekly to improve compliance. The supplements were consumed on 97% of the days on average and only 15 children dropped out of the study before the end of the 6 mo.
Indicators of iron, zinc, and vitamin A status
A 2-mL sample of fasting venous blood was collected from each preschooler at baseline and after 6 mo of supplementation. Blood was collected in a mineral-free evacuated tube and transferred to an acid-washed tube containing 0.05 mL sodium citrate as an anticoagulant. Hemoglobin was measured within 3 h (Coulter Electronics, Hialeah, FL). Plasma was separated by centrifugation at 1000 x g for 10 min at 20°C. Portions of plasma were frozen immediately and maintained at -70°C until analyzed. For plasma zinc measurements, samples were diluted 1:10 with deionized water and measured by atomic absorption spectrophotometry against a zinc reference (Sigma Chemical Co, St Louis) in 5% glycerol (42). Plasma ferritin was measured with a solid-phase immunoradioassay kit (Coat-A-Count Ferritin IRMA; Diagnostic Products Corp, Los Angeles). Vitamin A was extracted from plasma after the addition of retinyl myristate as an internal standard and was analyzed by isocratic reversed-phase HPLC using the method of Barua et al (43), with slight adaptations; the column was a Waters Resolve C18 (3.9 x 150 mm, 5-µm particle size; Millipore Corp, Milford, MA); the mobile phase consisted of acetonitrile, dichloroethane, methanol, and N-butanol (90:15:10:0.1); and the flow rate was 1 mL/min. The samples were analyzed at 300 nm. Plasma RBP and transthyretin were measured by immunoassay and laser nephelometry (Behring Diagnostics Inc, Somerville, NJ). C-reactive protein (CRP) was measured with the NA-Latex-CRP kit (Behring Diagnostics Inc). Analyses of all samples were performed in duplicate and were accompanied by standards and certified control sera. Control serum for vitamin A analysis was obtained from the National Institute of Standards and Technology (Standard Reference Materials; Gaithersburg, MD), control serum for zinc analysis was obtained from the Centers for Disease Control and Prevention (US Department of Health and Human Services, Atlanta), and control serum for ferritin, RBP, and transthyretin analyses were obtained from Bio-Rad (Anaheim, CA).
Statistical analysis
Biochemical data were analyzed as changes between basal and 6-mo values by using SAS (44). Group differences were analyzed by two-way analysis of variance using a Latin-square repeated-measures design that considers unequal numbers of subjects among treatment groups (Proc-GLM). Means were compared by using Tukey's range test. Group, sex, and initial vitamin A, iron, and zinc status (deficient or adequate) were used as independent variables. Cuttoff values for deficiency were 0.70 µmol/L for retinol, 12 µg/L for ferritin, and 10.7 µmol/L for zinc. Children with plasma CRP concentrations >5.0 mg/L were excluded from the statistical analyses because plasma retinol, RBP, transthyretin, and ferritin concentrations are altered by acute infection or inflammatory processes. Each dependent variable was tested for homogeneity of its variance by one-way analysis of variance and Bartlett's test. Values of P
0.05 were considered to be significant.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Previous studies showed a positive effect of zinc supplementation on vitamin A nutritional status (2325), suggesting a metabolic interaction between the 2 nutrients. Shingwekar et al (23) found a highly significant increase in plasma retinol and RBP after 40 mg Zn/d was given for 5 d to zinc-deficient, vitamin Adeficient Indian children with protein-energy malnutrition (PEM). The effect was not found in children without PEM who were less zinc deficient. Mean plasma concentrations of zinc, retinol, and RBP before supplementation were 8.7 µmol/L, 0.44 µmol/L, and 20 mg/L, respectively, in children with PEM and 11.1 µmol/L, 0.53 µmol/L, and 21.9 mg/L, respectively, in children without PEM.
Studies that showed no effect of zinc supplementation on vitamin A status were carried out in populations with no clear evidence of zinc deficiency (26, 27). Udomkesmalee et al (27) studied the effect of 6 mo of supplementation with 25 mg Zn/d on the vitamin A status of preschoolers in Thailand. They found no effect of zinc supplementation on plasma retinol or RBP. At baseline, children in that study had mean (±SD) plasma zinc and retinol concentrations of 13.2 ± 1.4 and 1.0 ± 0.2 µmol/L, respectively. Palin et al (26) found no effect of zinc supplementation on biochemical indicators of vitamin A status in patients with cystic fibrosis whose plasma zinc concentrations were within the normal range. The results of these studies are consistent with our observation that zinc supplementation benefits the metabolism of vitamin A when zinc status is poor.
In this study, baseline plasma concentrations of zinc and vitamin A predicted the response of vitamin A to zinc supplementation. The children were from a poor rural community at risk of marginal deficiency of several nutrients. On average, plasma zinc and retinol concentrations were within the normal range at baseline (14.7 and 1.05 µmol/L, respectively). Nevertheless, 29% of children had low plasma retinol (<0.70 µmol/L) and 25% had low plasma zinc (<10.7 µmol/L). Mean plasma concentrations of RBP and transthyretin were lower (22.8 ± 8.6 and 201.0 ± 51.0 mg/L, respectively) than those normally found in children with adequate vitamin A status (2676 and 250450 mg/L, respectively) (45). The effect of supplementation on plasma retinol concentrations was greater in the children deficient in zinc or vitamin A, strengthening the theory that zinc interactions with vitamin A metabolism are dependent on both zinc and vitamin A status. The effect of zinc supplementation on plasma retinol concentrations was greater in children who were vitamin A deficient at baseline than in children with adequate vitamin A status.
Studies in humans (28, 29, 3539, 4649) and animals (31, 50) showed associations between vitamin A deficiency and iron deficiency anemia. Vitamin A supplementation improves indicators of iron nutritional status, such as serum iron, transferrin, transferrin saturation, hematocrit, and hemoglobin, suggesting that vitamin A affects iron metabolism (35, 36, 39). In children (29, 3739, 4647) and in pregnant women (48), plasma hemoglobin and ferritin concentrations were correlated with plasma retinol and in some instances with RBP and transthyretin (36).
To our knowledge, only Mejía and Chew (35) studied the effect of iron supplementation on vitamin A status. These authors supplemented anemic children aged 18 y for 2 mo with either 3 mg elemental Fekgd-1 or iron plus vitamin A and evaluated the effect on plasma retinol and hematologic indicators. They did not find a beneficial effect of iron supplementation on serum retinol concentrations, but children in that study were not vitamin A deficient and were only marginally iron deficient. There are no reports of the effect of iron supplementation on plasma transport proteins of vitamin A. However, preliminary research with experimental iron-deficient animals showed a reduction in plasma concentrations of retinol even though the concentration of vitamin A in the liver was normal or higher than normal (F Rosales, J Beard, unpublished observations, 1999), suggesting that vitamin A use during iron deficiency is abnormal.
In this prospective mineral-supplementation study of freeliving children with a high incidence of iron deficiency (51% with low ferritin) and anemia (72% with low hemoglobin), we found that supplementation with iron alone or in combination with zinc improved vitamin A status. The effect was much stronger in children deficient in either iron or vitamin A than in children with adequate iron and vitamin A status. Moreover, the subjects who were zinc or iron deficient at baseline had lower retinol concentrations than did subjects with adequate zinc or iron status, although the difference was not significant for iron deficiency.
The fact that the children in our study had a higher incidence of low hemoglobin than of low plasma ferritin could be at least partially explained by the high incidence of other nutrient deficiencies. About 33% of our subjects had low vitamin B-12 concentrations, 29% were vitamin A deficient, and 32% had low riboflavin concentrations.
This study showed that supplementation for 6 mo with 2 times the recommended daily allowance (51) of iron and zinc improved vitamin A status as assessed by plasma concentrations of retinol, RBP, and transthyretin in children with a high risk of marginal deficiency of zinc, iron, and vitamin A. In developing populations, the coexistence of marginal vitamin A deficiency with zinc and iron deficiency is common. Attention to nutritional status for a single nutrient might not be appropriate (9, 10). We showed that vitamin A status is affected by zinc and iron deficiency, which could explain the failure of vitamin A status to improve in some vitamin A supplementation trials and programs (52). The precise mechanism by which these interactions occur requires further investigation.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. M. Fernandez-Real, J. M. Moreno, and W. Ricart Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance-Associated Iron Overload Diabetes, July 1, 2008; 57(7): 1918 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. T. Wieringa, J. Berger, M. A. Dijkhuizen, A. Hidayat, N. X. Ninh, B. Utomo, E. Wasantwisut, P. Winichagoon, and for the SEAMTIZI (South-East Asia Multi-country Tr Combined Iron and Zinc Supplementation in Infants Improved Iron and Zinc Status, but Interactions Reduced Efficacy in a Multicountry Trial in Southeast Asia J. Nutr., February 1, 2007; 137(2): 466 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Zimmermann, R. Biebinger, F. Rohner, A. Dib, C. Zeder, R. F Hurrell, and N. Chaouki Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 580 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Walker, K. Kordas, R. J Stoltzfus, and R. E Black Interactive effects of iron and zinc on biochemical and functional outcomes in supplementation trials Am. J. Clinical Nutrition, July 1, 2005; 82(1): 5 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Untoro, E. Karyadi, L. Wibowo, M. W. Erhardt, and R. Gross Multiple Micronutrient Supplements Improve Micronutrient Status and Anemia But Not Growth and Morbidity of Indonesian Infants: A Randomized, Double-Blind, Placebo-Controlled Trial J. Nutr., March 1, 2005; 135(3): 639S - 645S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Alarcon, P. W Kolsteren, A. M Prada, A. M Chian, R. E Velarde, I. L Pecho, and T. F Hoeree Effects of separate delivery of zinc or zinc and vitamin A on hemoglobin response, growth, and diarrhea in young Peruvian children receiving iron therapy for anemia Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1276 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. T Wieringa, M. A Dijkhuizen, C. E West, D. I Thurnham, Muhilal, and J. W. Van der Meer Redistribution of vitamin A after iron supplementation in Indonesian infants Am. J. Clinical Nutrition, March 1, 2003; 77(3): 651 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Backstrand, L. H Allen, A. K Black, M. de Mata, and G. H Pelto Diet and iron status of nonpregnant women in rural Central Mexico Am. J. Clinical Nutrition, July 1, 2002; 76(1): 156 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Allen Iron Supplements: Scientific Issues Concerning Efficacy and Implications for Research and Programs J. Nutr., April 1, 2002; 132(4): 813S - 819. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |